2565: Localized immunosuppression in vascular composite allotransplantation using hydrogel drug delivery system

BackgroundA major barrier for Vascularized Composite Allotransplants (VCA) to be more frequently advised is the necessity of long-term, systemic immunosuppression, elevating the risks of kidney and...